Literature DB >> 8515135

Increased phagocytosis and generation of reactive oxygen products by neutrophils and monocytes of men with stage 1 human immunodeficiency virus infection.

J C Bandres1, J Trial, D M Musher, R D Rossen.   

Abstract

Flow cytometry was used to study phagocytic function and release of reactive oxygen products following phagocytosis by neutrophils (PMNL) and monocytes of heparinized whole blood from stage 1 human immunodeficiency virus type 1 (HIV-1)-infected men. Phagocytic capacity was assessed by measuring uptake of Texas red-labeled bacteria. Reactive oxygen generation after phagocytosis was estimated by the quantity of dichlorofluorescein diacetate converted to dichlorofluorescein intracellularly. Compared with results in samples from age- and sex-matched controls, PMNL and monocytes from HIV-1-infected patients exhibited a significantly increased capacity to phagocytose Staphylococcus aureus and Escherichia coli and generate reactive oxygen products. These results are consistent with the hypothesis that stimuli associated with early HIV-1 infection enhance the nonspecific response of phagocytic cells to potential bacterial pathogens.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8515135     DOI: 10.1093/infdis/168.1.75

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  18 in total

1.  Impaired phagocytosis among patients infected by the human immunodeficiency virus: implication for a role of highly active anti-retroviral therapy.

Authors:  C Michailidis; G Giannopoulos; V Vigklis; K Armenis; A Tsakris; P Gargalianos
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

2.  Phagocytic function of monocytes in children with human immunodeficiency virus type 1 infection.

Authors:  G Tardei; D Duiculescu; C Capo; C C Diaconu; A Mutiu; J L Mege; C E Cernescu
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

Review 3.  Phagocytic activity in human immunodeficiency virus type 1 infection.

Authors:  Agostino Pugliese; Valerio Vidotto; Tiziana Beltramo; Donato Torre
Journal:  Clin Diagn Lab Immunol       Date:  2005-08

Review 4.  The immunocompromised host: HIV infection.

Authors:  James M Beck
Journal:  Proc Am Thorac Soc       Date:  2005

5.  In vitro evaluation of the role of humoral immunity against Bartonella henselae.

Authors:  M C Rodriguez-Barradas; J C Bandres; R J Hamill; J Trial; J E Clarridge; R E Baughn; R D Rossen
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

6.  Redox and activation status of monocytes from human immunodeficiency virus-infected patients: relationship with viral load.

Authors:  C Elbim; S Pillet; M H Prevost; A Preira; P M Girard; N Rogine; H Matusani; J Hakim; N Israel; M A Gougerot-Pocidalo
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

7.  Phenotypic and functional changes in peripheral blood monocytes during progression of human immunodeficiency virus infection. Effects of soluble immune complexes, cytokines, subcellular particulates from apoptotic cells, and HIV-1-encoded proteins on monocytes phagocytic function, oxidative burst, transendothelial migration, and cell surface phenotype.

Authors:  J Trial; H H Birdsall; J A Hallum; M L Crane; M C Rodriguez-Barradas; A L de Jong; B Krishnan; C E Lacke; C G Figdor; R D Rossen
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

Review 8.  Abnormalities in host defense associated with HIV infection.

Authors:  James M Beck
Journal:  Clin Chest Med       Date:  2013-04-08       Impact factor: 2.878

9.  Leptin stimulates the oxidative burst in control monocytes but attenuates the oxidative burst in monocytes from HIV-infected patients.

Authors:  C Sánchez-Pozo; J Rodriguez-Baño; A Domínguez-Castellano; M A Muniain; R Goberna; V Sánchez-Margalet
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

10.  Expression patterns of Fc gamma receptors, HLA-DR and selected adhesion molecules on monocytes from normal and HIV-infected individuals.

Authors:  C Locher; G Vanham; L Kestens; M Kruger; J L Ceuppens; J Vingerhoets; P Gigase
Journal:  Clin Exp Immunol       Date:  1994-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.